Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
2q2z | MKK | Kinesin-like protein KIF11 |
PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
---|---|---|---|---|---|
2q2z | MKK | Kinesin-like protein KIF11 | / | 1.000 | |
4a51 | DQ8 | Kinesin-like protein KIF11 | / | 0.631 | |
2g1q | N9H | Kinesin-like protein KIF11 | / | 0.616 | |
1q0b | NAT | Kinesin-like protein KIF11 | / | 0.591 | |
2x7d | EGB | Kinesin-like protein KIF11 | / | 0.585 | |
1x88 | NAT | Kinesin-like protein KIF11 | / | 0.574 | |
3k3b | L31 | Kinesin-like protein KIF11 | / | 0.572 | |
2fme | 3QC | Kinesin-like protein KIF11 | / | 0.566 | |
2x7e | X7E | Kinesin-like protein KIF11 | / | 0.562 | |
4bbg | V02 | Kinesin-like protein KIF11 | / | 0.560 | |
2gm1 | 2AZ | Kinesin-like protein KIF11 | / | 0.558 | |
2ieh | MOY | Kinesin-like protein KIF11 | / | 0.557 | |
3k5e | K5E | Kinesin-like protein KIF11 | / | 0.557 | |
3ken | ZZD | Kinesin-like protein KIF11 | / | 0.549 | |
2wog | ZZD | Kinesin-like protein KIF11 | / | 0.546 | |
2x7c | KZ9 | Kinesin-like protein KIF11 | / | 0.545 | |
2x2r | X2O | Kinesin-like protein KIF11 | / | 0.541 | |
4a5y | G7X | Kinesin-like protein KIF11 | / | 0.537 | |
2xae | 2XA | Kinesin-like protein KIF11 | / | 0.528 | |
4as7 | 6LX | Kinesin-like protein KIF11 | / | 0.494 | |
4z35 | ON9 | Lysophosphatidic acid receptor 1 | / | 0.464 | |
3cd5 | 7HI | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | 1.1.1.34 | 0.463 | |
1rfq | LAR | Actin, alpha skeletal muscle | / | 0.462 | |
4iay | ADP | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.462 | |
4z34 | ON7 | Lysophosphatidic acid receptor 1 | / | 0.461 | |
4ite | TEY | Vitamin D3 receptor | / | 0.458 | |
2gpv | OHT | Estrogen-related receptor gamma | / | 0.457 | |
1uu9 | BI3 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.455 | |
3qak | UKA | Adenosine receptor A2a | / | 0.455 | |
2bxe | 1FL | Serum albumin | / | 0.454 | |
3oaf | OAG | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
3w5p | 4OA | Vitamin D3 receptor | / | 0.454 | |
1bvr | THT | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.452 | |
2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.452 | |
2yek | EAM | Bromodomain-containing protein 2 | / | 0.451 | |
2yj5 | ATP | Copper-transporting ATPase | / | 0.451 | |
4ekl | 0RF | RAC-alpha serine/threonine-protein kinase | 2.7.11.1 | 0.451 | |
2fzm | FAD | Bifunctional protein PutA | 1.5.5.2 | 0.450 | |
3cin | NAD | Myo-inositol-1-phosphate synthase-related protein | / | 0.450 | |
4l2i | FAD | Electron transfer flavoprotein alpha/beta-subunit | / | 0.450 | |
1fm6 | BRL | Peroxisome proliferator-activated receptor gamma | / | 0.449 | |
2c3k | ABO | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.449 | |
2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.448 | |
3w5t | LHP | Vitamin D3 receptor | / | 0.448 | |
4fad | 0TB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.448 | |
3w5r | LOA | Vitamin D3 receptor | / | 0.447 | |
4enh | FVX | Cholesterol 24-hydroxylase | / | 0.447 | |
4jhz | 1KV | Beta-glucuronidase | 3.2.1.31 | 0.447 | |
2w1h | L0F | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.445 | |
3eb0 | DRK | Uncharacterized protein | / | 0.445 | |
4mq1 | 2C3 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 2.7.12.1 | 0.445 | |
5ify | TRH | Glucose-1-phosphate thymidylyltransferase | / | 0.445 | |
1err | RAL | Estrogen receptor | / | 0.444 | |
2a7r | 5GP | GMP reductase 2 | / | 0.444 | |
2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.444 | |
4eut | BX7 | Serine/threonine-protein kinase TBK1 | 2.7.11.1 | 0.444 | |
2gtn | LIE | Mitogen-activated protein kinase 14 | / | 0.443 | |
2ham | C33 | Vitamin D3 receptor | / | 0.443 | |
3r8p | Z46 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 | |
1q5k | TMU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.442 | |
2brn | DF1 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
2c3q | GTX | Glutathione S-transferase theta-1 | 2.5.1.18 | 0.442 | |
2f7x | 4EA | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.442 | |
1p44 | GEQ | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.441 | |
1u3d | FAD | Cryptochrome-1 | / | 0.441 | |
2om9 | AJA | Peroxisome proliferator-activated receptor gamma | / | 0.441 | |
3rm6 | 18Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.441 | |
1e90 | MYC | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.440 | |
1k6p | XN3 | Gag-Pol polyprotein | 3.4.23.16 | 0.440 | |
2itp | AEE | Epidermal growth factor receptor | 2.7.10.1 | 0.440 | |
2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
3qu0 | X40 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
4xuh | SFI | Peroxisome proliferator-activated receptor gamma | / | 0.440 |